Adjuvant Atezolizumab in Early-Stage Non–Small Cell Lung Cancer: Signals, Silences, and the Need for Methodological Clarity

J Jiebing He (Jiebing He, MD, Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang, China; Bo Zheng, MM, Department of Pediatrics, Shenyang Women’s and Children’s Hospital, Shenyang, China; and Zhenrong Wang, MD, Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang, China) B Bo Zheng Z Zhenrong Wang

Article Details

Volume / Issue Vol. 44, Issue 4
Published February 01, 2026
Pages 342-342
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

J

Jiebing He

Jiebing He, MD, Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang, China; Bo Zheng, MM, Department of Pediatrics, Shenyang Women’s and Children’s Hospital, Shenyang, China; and Zhenrong Wang, MD, Department of Thoracic Surgery, Liaoning Cancer Hospital, Shenyang, China

B

Bo Zheng

Z

Zhenrong Wang